Guangzhou Baiy | 600332 - Cost Of Sales


Guangzhou Baiy reported CNY18.55B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Aspen Pharmacare ZAR 9.63B 3.1B Dec/2025
Cipla INR 26.32B 2.79B Mar/2026
Dr.Reddys Laboratories INR 37.7B 1.54B Mar/2026
Jiangsu Hengrui CNY 1.09B 76.27M Mar/2026
Kalbe Farma IDR 5.46T 523.94B Sep/2025
Richter Gedeon HUF 72.45B 1.13B Mar/2026
Sh Fosun Pharma CNY 5.07B 507.9M Mar/2026
Sh Pharmaceutical CNY 60.51B 5.48B Dec/2025
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
Teva Pharmaceutical Industries USD 2.01B 46M Mar/2026